Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
32
33
Next >
Small Cap Biotechs Slammed By SVB Collapse
March 13, 2023
Tickers
SIVB
XBI
XLV
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Daily Stock Analysis: Eisai
March 13, 2023
Tickers
ESALY
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
Largest Psychedelic Stocks Down 13% Last Week; Down 20% YTD
March 13, 2023
Tickers
PSIL
Tags
Market News
Pharma/Biotech
From
TalkMarkets
Week In Review: Sino Biopharma Acquires F-Star For $161 Million After US Approval
March 11, 2023
Tickers
AMAM
FSTX
SBMFF
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
MindMed: Researching LSD And MNMA To Treat Neurological Diseases
March 08, 2023
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Compass Pathways - Entering A Brave New World
March 07, 2023
Tickers
CMPS
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading
March 06, 2023
Tickers
ABBV
ABT
GILD
IWM
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
GH Resources: Focus On Treatment-Resistant Depression Paying Off
March 06, 2023
Tickers
GHRS
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
An Aggressive ETF Portfolio For 2023
March 05, 2023
Tickers
BITO
MSOS
POTX
PSIL
Tags
Pharma/Biotech
Market News
Healthcare
From
TalkMarkets
Week In Review: Abbisko Out-Licenses Rights To Precision NSCLC Medicine For $188 Million
March 04, 2023
Tickers
MRK
Tags
Market News
Pharma/Biotech
From
TalkMarkets
Alkermes: Commercialization Program On Track, Sales Coming In Strong
March 04, 2023
Tickers
ALKS
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
Update: SciSparc To Spin Off Pharmaceutical Activities Into New Subsidiary
March 01, 2023
Tickers
SPRC
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio By 2-To-1 Margin YTD
February 26, 2023
Tickers
ACRDF
CYBN
MNMD
MSOS
Tags
Healthcare
Consumer Goods
Market News
From
TalkMarkets
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
February 26, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
Recent Stock Purchase/Sale February 2023
February 26, 2023
Tickers
ABBV
GEHC
HLN
VFC
Tags
Stocks / Equities
Market News
Communications
From
TalkMarkets
Week In Review: Keymed/Lepu Sign $1.2 Billion Deal Out-Licensing Claudin 18.2 ADC To AstraZeneca
February 25, 2023
Tickers
AZN
BGNE
BIIB
KNTE
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
Only 2 Of 5 Cannabis Categories Have Advanced YTD
February 25, 2023
Tickers
ACB
ACRDF
AFCG
BTI
Tags
Services
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
ZYNE: Nano-Cap Company That Is Focused On Treatments For Neuropsychiatric Disorders
February 20, 2023
Tickers
ZYNE
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Novo Nordisk: Impulsive Sequence Favors Upside & Remain Supported
February 19, 2023
Tickers
NVO
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Week In Review: China Biopharmas Announce Three Out-Licensing Deals Totaling $2 Billion
February 18, 2023
Tickers
CGEM
CHJTF
CHRS
CRBP
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
February 17, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
AMGN Near Buy Point With Strong Fundamentals And Rising Dividend
February 16, 2023
Tickers
AMGN
Tags
Healthcare
Pharma/Biotech
Market News
From
TalkMarkets
Tuesday Talk: My Sweet CPI
February 14, 2023
Tickers
AAPL
ABBV
AMGN
BITCOMP
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers
February 13, 2023
Tickers
ABBV
BMY
GILD
IBB
Tags
Healthcare
ETFs
Pharma/Biotech
From
TalkMarkets
GlycoMimetics Audio Discussion And Analysis With Dan Cohen And Scott Matusow
February 13, 2023
Tickers
ABBV
GLYC
JAZZ
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
"Rags-To-Riches" Portfolio Down 8% Last Week
February 13, 2023
Tickers
CGC
CRON
GHRS
TLRY
Tags
Consumer Goods
Healthcare
Pharma/Biotech
From
TalkMarkets
"Multi-Bagger" Portfolio Update
February 12, 2023
Tickers
ACRDF
AYR
CYBN
MNMD
Tags
Healthcare
Consumer Goods
Market News
From
TalkMarkets
Top CRISPR Stocks
February 11, 2023
Tickers
CRSP
EDIT
NTLA
NVS
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Major Psychedelic Compound-Based Stocks UP 13% YTD
February 11, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
Week In Review: CANbridge In-Licenses Gene Therapy For Rare Disease From UMass
February 11, 2023
Tickers
GSK
KNTPF
PHASQ
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.